Severe refractory CIDP: a case series of 10 patients treated with bortezomib
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Neurology"
DOI: 10.1007/s00415-017-8599-4
Abstract: Treatment options for patients with aggressive chronic inflammatory demyelinating neuropathy are limited and include the anti-CD20 antibody rituximab and the immunosuppressive regime cyclophosphamide. We aimed to investigate retrospectively the efficacy of bortezomib, a proteasome inhibitor… read more here.
Keywords: bortezomib; treatment; refractory cidp; case series ... See more keywords